Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Wellness
Interventions: Wellness Intention; Other
Lead sponsor: Merraki Institute; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Breast Cancer, Breast-conserving Surgery, Breast Cancer - Infiltrating Ductal Carcinoma, ER/PR+Her2neu, Grade I, II, III
Interventions: Radiofrequency ablation alone, Radiofrequency ablation Electrosurgical Device; Device
Lead sponsor: Innoblative Designs, Inc.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Contraception
Interventions: Etonogestrel Implant; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,076 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2021
U.S. locations: 2
States / cities: Indianapolis, Indiana • St Louis, Missouri

Conditions: Arrhythmia, Atrial Fibrillation
Interventions: Sentinel® Cerebral Protection System, Magnetic Resonance Imaging; Device · Diagnostic Test
Lead sponsor: Malini Madhavan; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mild Cognitive Impairment, Early Alzheimer's Disease, Memory Impairment
Interventions: COT, Sham; Drug
Lead sponsor: Evon Medics LLC; Industry
Eligibility: 55 Years to 95 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Washington D.C., District of Columbia

Conditions: Sleep
Interventions: Phototherapy device; Device
Lead sponsor: University of Arizona; Other
Eligibility: 30 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Complex Abdominal Aortic Aneurysm
Interventions: Fenerated AAA Endovascular Graft with H&L-B One Shot Introduction System; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 70 Years to 70 Years · Male only
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy Related, Fetal Distress
Interventions: Novii ECG/EKG System, External fetal heart rate monitoring; Device
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 4
States / cities: Murray, Utah • Ogden, Utah • Provo, Utah + 1 more

Conditions: Vestibular Disease
Interventions: Electrotactile sensory substitution; Device
Lead sponsor: Wicab; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 4
States / cities: Jacksonville, Florida • Rochester, Minnesota • St Louis, Missouri + 1 more

Conditions: Asthma
Interventions: Budesonide/formoterol fumarate Aerosphere, Budesonide/formoterol fumarate pMDI; Combination Product
Lead sponsor: AstraZeneca; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 6
States / cities: Long Beach, California • Miami, Florida • Lafayette, Louisiana + 3 more

Conditions: Wide Neck Bifurcation Intracranial Aneurysms
Interventions: WEB; Device
Lead sponsor: Microvention-Terumo, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 29
States / cities: Hollywood, Florida • Orlando, Florida • Honolulu, Hawaii + 22 more

Conditions: Brain Concussion, Brain Injuries
Interventions: HS-1000 recording; Device
Lead sponsor: HeadSense Medical; Industry
Eligibility: 13 Years to 25 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Neurologic Disorder
Interventions: Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics, Standard inpatient rehabilitation therapy; Device · Other
Lead sponsor: Rehabilitation Hospital of Overland Park; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Cardiovascular Risk Factor, Nicotine Dependence
Interventions: Electronic Cigarette; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Breast Cancer
Interventions: CBCT Scan, OBI KV Imaging; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Aortic Aneurysm, Aortic Aneurysm and Dissection, Aortic Diseases, Aneurysm of Aorta, Thoracic, Aneurysmal Disease, Aorta, Thoracic Pathologies
Interventions: Rapidlink; Device
Lead sponsor: Vascutek Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 15
States / cities: Los Angeles, California • Aurora, Colorado • Washington D.C., District of Columbia + 11 more

Conditions: Pancreatic Adenocarcinoma Non-resectable
Interventions: ACT Implantable Iontophoresis Chemotherapy Delivery Device with Gemcitabine (ACT-IOP-003); Combination Product
Lead sponsor: Continuity Biosciences, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Morgantown, West Virginia

Conditions: Restless Legs Syndrome
Interventions: AirCast Sequential Compression Device; Device
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Sleep Disorders Center, Walter Reed Army Medical Center, District of Columbia

Conditions: Body Fat
Interventions: TempSure; Device
Lead sponsor: Cynosure, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 6
States / cities: Hunt Valley, Maryland • New York, New York • Rye, New York + 3 more

Conditions: Depressive Symptoms, Urinary Incontinence, Sexual Dysfunction
Interventions: EXOMIND (BTL-699-2) Active Treatment, EMSELLA (HPM-6000UF) ActiveTreatment, EXOMIND (BTL-699-2) Sham Treatment, EMSELLA (HPM-6000UF) Sham Treatment; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Winter Garden, Florida • Wellesley, Massachusetts

Conditions: Lymphedema of Leg, Lymphedema, Lymphedema, Secondary, Lymphedema Primary, Lymphedema, Lower Limb
Interventions: Aria Health Aria Free, A Traditional PCD; Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: End Stage Heart Disease, Right Ventricular Dysfunction
Interventions: inhaled nebulized milrinone; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Pneumonia
Interventions: Amikacin (BAY41-6551), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 7
States / cities: Birmingham, Alabama • Melbourne, Florida • Albany, New York + 4 more

Conditions: Treatment for Cellulite on the Stomach and Flanks
Interventions: Cutera truSculpt Device; Device
Lead sponsor: Cutera Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 3
States / cities: Sacramento, California • Glencoe, Illinois • New York, New York

Search by objective public record fields.

Consciousness Field Project: Intention Host Device-mediated Distant Intentionality

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Effectiveness of Prolonged Use of IUD/Implant for Contraception

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease

Phase II Study - Trial of a Phototherapy Light Device to Improve Sleep Health

Compassionate Use Treatment for a Single Patient With a Custom Made Branched/Fenestrated Endovascular Device for the Treatment of Complex Abdominal Aortic Aneurysm

Novii External Fetal Monitoring Device

Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction

A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion

IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Sequential Compression Devices for Treatment of Restless Legs Syndrome

Multi-Center Pivotal Study of Radiofrequency Device

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema

Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Multi-Center Pilot Study of Cutera truSculpt Device